Adult onset lung disease following transient disruption of fetal stretch-induced differentiation

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Hudak, Joseph J ^a   Killeen, Erin ^a   Chandran, Ashok ^a   Cohen, J Craig ^a   Larson, Janet E ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR; COMPLEMENTARY DNA; COMPLEMENTARY RNA; PEPTIDE FRAGMENT;

ADULT DISEASE; AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREATHING; CONTROLLED STUDY; FETUS; FETUS DEVELOPMENT; GENE INSERTION; HISTOPATHOLOGY; KNOCKOUT GENE; LUNG; LUNG COMPLIANCE; LUNG DEVELOPMENT; LUNG DISEASE; LUNG STRUCTURE; NONHUMAN; PRESSURE VOLUME CURVE; RAT; RESPIRATORY FUNCTION; ADULT; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; FEMALE; GENE TRANSFER; GENETICS; HUMAN; LUNG FUNCTION TEST; MOLECULAR CLONING; MYOTATIC REFLEX; ONSET AGE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT;

ADULT; AGE OF ONSET; ANIMALS; CELL DIFFERENTIATION; CLONING, MOLECULAR; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA, ANTISENSE; FEMALE; FETUS; GENE TRANSFER TECHNIQUES; HUMANS; LUNG; LUNG DISEASES; PEPTIDE FRAGMENTS; PREGNANCY; RATS; REFLEX, STRETCH; RESPIRATORY FUNCTION TESTS; RNA, ANTISENSE;

EID: 70249098142     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-34     Document Type: Article

References (56)

1. Cohen JC, Larson JE. The Peter Pan paradigm. Theor Biol Med Model 2008, 5:1. 2249573, 18182112, 10.1186/1742-4682-5-1.
2. Gillman MW, Rich-Edwards JW. The fetal origin of adult disease: from sceptic to convert. Paediatr Perinat Epidemiol. 2000, 14(3):192-193. 10.1046/j.1365-3016.2000.00265.x, 10949210.
3. Morris JA. Fetal origin of maturity-onset diabetes mellitus: genetic or environmental cause?. Medical hypotheses 1998, 51(4):285-288. 10.1016/S0306-9877(98)90048-2, 9824831.
4. Rocchini AP. Fetal and pediatric origins of adult cardiovascular disease. Current opinion in pediatrics 1994, 6(5):591-595. 10.1097/00008480-199410000-00015, 7820207.
5. Yang Y, Beqaj S, Kemp P, Ariel I, Schuger L. Stretch-induced alternative splicing of serum response factor promotes bronchial myogenesis and is defective in lung hypoplasia. The Journal of clinical investigation 2000, 106(11):1321-1330. 387248, 11104785, 10.1172/JCI8893.
6. Liu M, Post M. Invited review: mechanochemical signal transduction in the fetal lung. J Appl Physiol 2000, 89(5):2078-2084.
7. Moore KA, Polte T, Huang S, Shi B, Alsberg E, Sunday ME, Ingber DE. Control of basement membrane remodeling and epithelial branching morphogenesis in embryonic lung by Rho and cytoskeletal tension. Dev Dyn 2005, 232(2):268-281. 10.1002/dvdy.20237, 15614768.
8. Cohen JC, Larson JE. Cystic fibrosis transmembrane conductance regulator (CFTR) dependent cytoskeletal tension during lung organogenesis. Dev Dyn 2006, 235(10):2736-2748. 10.1002/dvdy.20912, 16906518.
9. Larson JE, Cohen JC. Developmental paradigm for early features of cystic fibrosis. Pediatr Pulmonol 2005, 40(5):371-377. 10.1002/ppul.20169, 15830387.
10. Cohen JC, Larson JE, Killeen E, Love D, Takemaru K. CFTR and Wnt/beta-catenin signaling in lung development. BMC developmental biology 2008, 8:70. 2464600, 18601749, 10.1186/1471-213X-8-70.
11. Rehan VK, Torday JS. Exploiting the PTHrP signaling pathway to treat chronic lung disease. Drugs Today (Barc) 2007, 43(5):317-331. 10.1358/dot.2007.43.5.1062665, 17724498.
12. Torday JS, Rehan VK. Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatric research 2007, 62(1):2-7. 10.1203/PDR.0b013e31806772a1, 17515838.
13. Torday JS, Rehan VK. The evolutionary continuum from lung development to homeostasis and repair. Am J Physiol Lung Cell Mol Physiol 2007, 292(3):L608-611. 10.1152/ajplung.00379.2006, 17085519.
14. Torday JS, Rehan VK. Up-regulation of fetal rat lung parathyroid hormone-related protein gene regulatory network down-regulates the Sonic Hedgehog/Wnt/betacatenin gene regulatory network. Pediatric research 2006, 60(4):382-388. 10.1203/01.pdr.0000238326.42590.03, 16940239.
15. Sanchez-Esteban J, Tsai SW, Sang J, Qin J, Torday JS, Rubin LP. Effects of mechanical forces on lung-specific gene expression. The American journal of the medical sciences 1998, 316(3):200-204. 10.1097/00000441-199809000-00009, 9749563.
16. Larson JE, Morrow SL, Delcarpio JB, Bohm RP, Ratterree MS, Blanchard JL, Cohen JC. Gene transfer into the fetal primate: evidence for the secretion of transgene product. Mol Ther 2000, 2(6):631-639. 10.1006/mthe.2000.0209, 11124065.
17. Sekhon HS, Larson JE. In utero gene transfer into the pulmonary epithelium. Nat Med 1995, 1(11):1201-1203. 10.1038/nm1195-1201, 7584996.
18. Garrett DJ, Larson JE, Dunn D, Marrero L, Cohen JC. In utero recombinant adeno-associated virus gene transfer in mice, rats, and primates. BMC Biotechnol 2003, 3(1):16. 239997, 14519209, 10.1186/1472-6750-3-16.
19. Garrett DJ, Cohen JC, Larson JE. Long term physiologic modification using rAAV in utero gene-therapy. Genet Vaccines Ther 2004, 2(1):4. 420496, 15151697, 10.1186/1479-0556-2-4.
20. Larson JE, Delcarpio JB, Farberman MM, Morrow SL, Cohen JC. CFTR modulates lung secretory cell proliferation and differentiation. Am J Physiol Lung Cell Mol Physiol 2000, 279(2):L333-341.
21. Morrow SL, Larson JE, Nelson S, Sekhon HS, Ren T, Cohen JC. Modification of development by the CFTR gene in utero. Mol Genet Metab. 1998, 65(3):203-212. 10.1006/mgme.1998.2755, 9851885.
22. Cohen JC, Morrow SL, Cork RJ, Delcarpio JB, Larson JE. Molecular pathophysiology of cystic fibrosis based on the rescued knockout mouse model. Mol Genet Metab 1998, 64(2):108-118. 10.1006/mgme.1998.2683, 9705235.
23. Larson JE, Morrow SL, Happel L, Sharp JF, Cohen JC. Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 1997, 349(9052):619-620. 10.1016/S0140-6736(05)61567-X, 9057739.
24. Cohen JC, Scott D, Miller J, Zhang J, Zhou P, Larson JE. Transient in utero knockout (TIUKO) of C-MYC affects late lung and intestinal development in the mouse. BMC developmental biology 2004, 4:4. 419337, 15090077, 10.1186/1471-213X-4-4.
25. Cohen JC, Larson JE. Pathophysiologic consequences following inhibition of a CFTR-dependent developmental cascade in the lung. BMC developmental biology 2005, 5(1):2. 549215, 15694001, 10.1186/1471-213X-5-2.
26. Larson JE, Cohen JC. Improvement of Pulmonary Hypoplasia Associated with Congenital Diaphragmatic Hernia by In Utero CFTR Gene Therapy. Am J Physiol Lung Cell Mol Physiol 2006,
27. Davies LA, Varathalingam A, Painter H, Lawton AE, Sumner-Jones SG, Nunez-Alonso GA, Chan M, Munkonge F, Alton EW, Hyde SC, et al. Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice. Mol Ther 2008, 16(5):812-818. 10.1038/mt.2008.25, 18388934.
28. Kim BM, Mao J, Taketo MM, Shivdasani RA. Phases of canonical Wnt signaling during the development of mouse intestinal epithelium. Gastroenterology 2007, 133(2):529-538. 10.1053/j.gastro.2007.04.072, 17681174.
29. Cohen JC, Larson JE. Pathophysiologic consequences following inhibition of a CFTR-dependent developmental cascade in the lung. BMC Dev Biol 2005, 5:2. 549215, 15694001, 10.1186/1471-213X-5-2.
30. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 1992, 72(1):168-178. 10.1063/1.352153, 1537711.
31. Tomioka S, Bates JH, Irvin CG. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J Appl Physiol 2002, 93(1):263-270.
32. Lutchen KR, Hantos Z, Petak F, Adamicza A, Suki B. Airway inhomogeneities contribute to apparent lung tissue mechanics during constriction. J Appl Physiol 1996, 80(5):1841-1849.
33. Hayden MJ, Petak F, Hantos Z, Hall G, Sly PD. Using low-frequency oscillation to detect bronchodilator responsiveness in infants. Am J Respir Crit Care Med 1998, 157(2):574-579.
34. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM. Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 1997, 45(11):1559-1565.
35. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 1970, 26(1):57-60.
36. Broussard D, Larson JE, Cohen JC, Lundblad LK. Developmental changes in respiratory mechanics in the neonatal rat. Exp Lung Res 2006, 32(6):263-273. 10.1080/01902140600817549, 16908451.
37. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001, 22(1):32-39. 10.1016/S0165-6147(00)01596-0, 11165670.
38. Davis SD, Fordham LA, Brody AS, Noah TL, Retsch-Bogart GZ, Qaqish BF, Yankaskas BC, Johnson RC, Leigh MW. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 2007, 175(9):943-950. 10.1164/rccm.200603-343OC, 17303797.
39. Failo R, Wielopolski PA, Tiddens HA, Hop WC, Mucelli RP, Lequin MH. Lung morphology assessment using MRI: a robust ultra-short TR/TE 2D steady state free precession sequence used in cystic fibrosis patients. Magn Reson Med 2009, 61(2):299-306. 10.1002/mrm.21841, 19165879.
40. Kremer TM, Zwerdling RG, Michelson PH, O'Sullivan P. Intensive care management of the patient with cystic fibrosis. J Intensive Care Med 2008, 23(3):159-177. 10.1177/0885066608315679, 18443012.
41. Robinson TE, Goris ML, Zhu HJ, Chen X, Bhise P, Sheikh F, Moss RB. Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis. Chest 2005, 128(4):2327-2335. 10.1378/chest.128.4.2327, 16236891.
42. Seferian EG, Henry NK, Wylam ME. High-frequency oscillatory ventilation in an infant with cystic fibrosis and bronchiolitis. Respiratory medicine 2006, 100(8):1466-1469. 10.1016/j.rmed.2005.11.015, 16403615.
43. Tiddens HA, de Jong PA. Imaging and clinical trials in cystic fibrosis. Proceedings of the American Thoracic Society 2007, 4(4):343-346. 10.1513/pats.200611-174HT, 17652498.
44. Failo R, Wielopolski PA, Tiddens HA, Hop WC, Pozzi Mucelli R, Lequin MH. Lung morphology assessment using MRI: A robust ultra-short TR/TE 2D steady state free precession sequence used in cystic fibrosis patients. Magn Reson Med 2009, 61(2):299-306. 10.1002/mrm.21841, 19165879.
45. Verhaeghe C, Delbecque K, de Leval L, Oury C, Bours V. Early inflammation in the airways of a cystic fibrosis foetus. J Cyst Fibros 2007, 6(4):304-308. 10.1016/j.jcf.2006.12.001, 17223612.
46. Cigana C, Assael BM, Melotti P. Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother 2007, 51(3):975-981. 1803122, 17210769, 10.1128/AAC.01142-06.
47. Cigana C, Nicolis E, Pasetto M, Assael BM, Melotti P. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 2006, 350(4):977-982. 10.1016/j.bbrc.2006.09.132, 17045242.
48. Heijerman H. Infection and inflammation in cystic fibrosis: a short review. J Cyst Fibros 2005, 4(Suppl 2):3-5. 10.1016/j.jcf.2005.05.005, 15970469.
49. Ferrara G, Losi M, Franco F, Corbetta L, Fabbri LM, Richeldi L. Macrolides in the treatment of asthma and cystic fibrosis. Respir Med 2005, 99(1):1-10. 10.1016/j.rmed.2004.09.014, 15672842.
50. Nijland MJ, Ford SP, Nathanielsz PW. Prenatal origins of adult disease. Curr Opin Obstet Gynecol 2008, 20(2):132-138. 10.1097/GCO.0b013e3282f76753, 18388812.
51. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005, 85(2):571-633. 10.1152/physrev.00053.2003, 15788706.
52. Wu G, Bazer FW, Cudd TA, Meininger CJ, Spencer TE. Maternal nutrition and fetal development. J Nutr 2004, 134(9):2169-2172.
53. Brawley L, Poston L, Hanson MA. Mechanisms underlying the programming of small artery dysfunction: review of the model using low protein diet in pregnancy in the rat. Arch Physiol Biochem 2003, 111(1):23-35. 10.1076/apab.111.1.23.15138, 12715272.
54. Bertram CE, Hanson MA. Prenatal programming of postnatal endocrine responses by glucocorticoids. Reproduction 2002, 124(4):459-467. 10.1530/rep.0.1240459, 12361463.
55. Young LE. Imprinting of genes and the Barker hypothesis. Twin Res 2001, 4(5):307-317. 10.1375/1369052012632, 11869481.
56. Barker DJ. The fetal and infant origins of adult disease. BMJ 1990, 301(6761):1111. 1664286, 2252919, 10.1136/bmj.301.6761.1111.